{
    "2021-09-16": [
        [
            {
                "time": "",
                "original_text": "上海医药拟向上海潭东、云南白药定增143.84亿元 “存贷双高”成监管关注重点",
                "features": {
                    "keywords": [
                        "上海医药",
                        "定增",
                        "143.84亿元",
                        "存贷双高",
                        "监管关注"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "神秘机构A股扫货！全球第三大主权基金加仓这些板块",
                "features": {
                    "keywords": [
                        "神秘机构",
                        "A股",
                        "扫货",
                        "主权基金",
                        "加仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "未明确提及"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}